-
Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution
•
Jointown Pharmaceutical Group Co., Ltd (SHA: 600998), China’s largest private pharmaceutical distributor, has partnered with Shandong DYNE Marine Biopharmaceutical Co., Ltd., a state-owned firm specializing in pediatric medications. The collaboration aims to integrate Jointown’s nationwide logistics network with DYNE’s R&D expertise in pediatric drugs. Jointown’s Distribution EdgeJointown operates a logistics…
-
Convalife and Jointown Partner for Global Drug Development and Commercialization
•
Shanghai-based Convalife Pharmaceuticals has entered into a strategic partnership with fellow Chinese firm Jointown Pharmaceutical Group Co., Ltd (SHA: 600998) to collaborate on new drug development and the global research, development, and commercialization of related products. The partnership aims to leverage the strengths of both companies to advance innovative cancer…
-
China Pharma H1 2022 Financials: 40% of Firms Report Revenue and Profit Growth
•
A total of 449 pharmaceutical and health-tech companies listed in China have released their H1 2022 financial reports, with over 40% reporting growth in both revenues and net profits. Among these, 14 companies recorded net profits exceeding RMB 2 billion (USD 287 million). Andon Health led the pack with RMB…
